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Abstract
Objectives
In children suffering from febrile seizure, the likelihood of recurrence 
seems to be high in the early hours following the first episodes in 
the absence of proper interventions. The present study was aimed 
at assessing and comparing the outcomes of different preventive 
interventions in the acute stage after febrile seizure in children.
Materials & Methods
This randomized clinical trial study was performed between September 
2015 and September 2016. We enrolled patients aged between 6 and 
60 months suffered from febrile seizure and referred to the Pediatric 
Emergency Department at Besat Hospital in Hamadan. The eligible 
patients were randomly assigned to the following four receive one of 
the following groups: group 1 (not receiving any anti-seizure drugs), 
group 2 (receiving a single dose of phenobarbital) on admission, group 
3 (receiving a single dose of phenobarbital on admission continued 
until the fever is resolved), and group 4 (receiving diazepam until the 
disappearance of fever). 
Results
The study population consisted of 248 children. The recurrence rate 
of seizure in the acute stage was 4.84%. Also, the impact of diazepam 
and phenobarbital (either as a single dose or as continuous) on the 
prevention of febrile seizure recurrence in the acute stage has been 
established. None of the patients had febrile status epilepticus. 
Conclusion
Controlling seizures without prescribing anti-seizure drugs increases 
the risk for the recurrence of febrile seizure in the acute stage. 
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Introduction
Febrile convulsions (FC) denote seizures occurring 
in febrile children aged between the ages of 6 
and 60 months who do not have an intracranial 
infection, metabolic disturbance, or history of 
afebrile seizures. Febrile seizures are subdivided 
into the two categories of simple and complex. 
Simple febrile seizures last for less than 15 minutes, 
are generalized (without a focal component), and 
occur once in a 24-hour period, whereas complex 
febrile seizures are prolonged (15 minutes) and 
focal or occur more than once in 24 hours (1). 
Despite the frequency of febrile seizures (2%–
5%), there is no unanimity of opinion regarding 
management options (1,2, 3,4). When a single FC 
or repetitive FC last more than 30 min without 
the recovery of the normal consciousness, a 
febrile status epilepticus occurs (5). Experimental 
studies performed in the 80s showed that the 
central nervous system (CNS) homeostasis was 
constitutively altered in the case of seizures 
lasting more than 30 min (6). In this regard, the 
literature suggests that short seizure duration may 
reduce CNS risk factors. On the other hand, further 
studies showed that a single epileptic event usually 
resolves within 2–5 min, while those critical events 
lasting more than 10–15 min show a higher risk 
and are not spontaneously resolved (7). Although 
this phenomenon is naturally benign, it may lead 
to severe anxiety among parents (8). Besides its 
benign nature, the high likelihood of some serious 
complications, such as status epilepticus and mesial 
temporal sclerosis, highlight the importance of the 
early management of febrile seizure (9). 
In this regard, recurrent febrile seizure is primarily 
critical. Several factors have been identified to 
increase the risk for recurrent febrile seizure, 
including age less than one year at the time of 
the first seizure, family history of febrile seizure 
in relatives, low fever during seizure, and the 
occurrence of complex seizures (10,11). The 
optimal management of febrile seizure is mainly 
based on three steps, including 1) management 
of the patient at the time of seizure and status 
epilepticus, 2) management of the recurrence 
of febrile seizure in the early hours after seizure 
interruption, and 3) management of the recurrence 
of febrile seizure in the next febrile courses 
(12,13). In the first step, the treatment protocol is 
similar to the seizure conditions without fever. In 
subsequent steps, the early prevention of seizure 
can result in favorable outcomes. Due to the benign 
nature of this event, it is not necessary to follow an 
especial preventive or therapeutic protocol, except 
for those conditions with a high risk for recurrent 
episodes or stress in parents (14). Moreover, in 
the third step, two preventive approaches are now 
accepted, including intermittent treatment with 
Different drug regimens for controlling seizure, including diazepam 
and phenobarbital (as stat or maintenance), may play a similar role in 
preventing the occurrence of febrile seizure.  
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oral diazepam only during the onset of fever and 
long-term treatment with phenobarbital or sodium 
valproate daily (15). In total, and according to 
some evidence, the likelihood of recurrence is 
high in the early hours in the absence of proper 
interventions (16). Furthermore, using various 
preventive interventions may lead to different 
outcomes in affected children. The present study 
was aimed at assessing and comparing the outcome 
of different preventive interventions in the early 
hours after febrile seizure. The aim of this study 
was to evaluate the effect of prophylaxis treatment 
in acute FC  stage  until  fever subsides.
Materials & Methods
This randomized clinical trial was conducted 
among children aged between  6 and 60 months 
and suffered from febrile seizure who referred 
to the Pediatric Emergency Department at Besat 
Hospital in Hamadan between September 2014 
and September 2015. The inclusion criteria were 
the occurrence of simple febrile seizure for the first 
time, complex febrile seizure (up to two times) 
defined as seizures lasting >15 min and/or focal 
and/or repetitive within 24 h and/or with postictal 
neurological abnormalities, recurrent febrile seizure 
up to two times, the presence of fever (higher than 
37.5ºC axillary at the time of seizure), no history 
of previous seizures without fever, and absence of 
a neurological development disorder or a previous 
lesion of the brain. The exclusion criteria comprised 
of status epilepticus, change in the diagnosis, 
including meningitis or encephalitis, the presence 
of electrolyte disturbances in seizure, including 
hypoglycemia and hypocalcemia, lack of parental 
cooperation, serial seizures before admission to the 
hospital (more than twice), any abnormalities in 
brain imaging, allergy to phenobarbital manifested 
by rash, or Stevens-Johnson syndrome or TEN. The 
eligible patients were randomly (using the block 
randomization method) assigned to receive one of 
the following protocols: group 1 (not receiving any 
anti-seizure drugs), group 2 (receiving a single dose 
of phenobarbital (10 mg/kg, IM) on admission), 
group 3 (receiving a single dose of phenobarbital 
(10 mg/kg, IM) on admission followed by 2.5 mg/
kg/12 hour, IM and then beginning of oral regimen 
as phenobarbital (2.5 mg/kg, OR) until fever 
subsided, and group 4 (receiving Tab diazepam 
(0.33 mg/kg/q8h) until fever was gone).
In cases with the recurrence of seizure (regardless 
of the study group), phenobarbital as 10 mg/kg 
was administered IM  followed by 2.5 mg/kg/12h 
intramuscularly. In cases with status epilepticus 
(more than 30 minutes or two consecutive seizures 
with lack of consciousness among seizures lasting 
more than 30 minutes), the routine protocol for 
treating status epilepticus was followed. All 
the patients were evaluated with regard to the 
cause of fever. In cases with uncontrolled fever, 
acetaminophen (10 to 15 mg/kg) in the form of 
syrup was administered. Supplementary studies, 
including laboratory analyses and CSF analysis or 
imaging, were planned if required.
Results are presented as mean ± standard deviation 
(SD) for quantitative variables and as frequency 
(percentage) for categorical variables. Continuous 
variables were compared using ANOVA or Kruskal-
Wallis test whenever the data did not appear to 
have a normal distribution or when the assumption 
of equal variances was violated across the study 
groups. Categorical variables, on the other hand, 
were compared using the Chi-square test. A P-value 
of less than 0.05 was considered statistically 
significant, SPSS version 23.0 for windows (IBM, 
Armonk, New York) was used for data analysis.
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Results
In total, 248 patients (129 male and 119 female, 
mean age: 22.00 ± 10.98 months, age range: 6 to 
60 months) were included. Regarding drug-related 
regimens for controlling seizure, 68 patients were 
considered as the control without planning for anti-
seizure medication, 63 patients received diazepam, 
59 patients received a single dose of phenobarbital, 
and 58 patients were planned for treatment with 
continuous phenobarbital administration. 
Overall, 95.6% of the patients had no recurrent 
seizure, and 4.84% the was recurrence rate  of 
FC (4.4% experienced seizure once and only 
0.4% experienced it twice). Recurrence rate was 
13.2% (11.8% had one episode and 1.5% had 
two episodes) in the non-drug  group, 3.2% in the 
diazepam group, and 1.7% in the single dose of 
phenobarbital group (P=0.000; Table 1). None of 
the patients had febrile status epilepticus.
Regarding the type of seizure, simple seizure was 
found in 79.4% of the patients, complex in 5.2 
%, and recurrence in 15.3%. The mean of body 
temperature was measured to be 38.64 degrees 
(range: 37 to 41); specifically, 107 patients  had 
fever below 38.5 degrees and 141 patients had 
fever above 38.5 degrees. The main causes of fever 
were respiratory infectious disorders (86.7%), 
gastrointestinal infections (9.7%), urinary tract 
infections (0.8%), and other infectious conditions 
(2.8%). Family history of seizure and febrile 
seizure was found in 14.1% and 26.6% of the 
cases, respectively. The mean time between the 
appearance of fever and seizure was 35.19 hours; 
in detail, in 203 patients it was less than 24 hours, 
and in 45 cases it was more than 24 hours. None 
of the patients had  hyponatremia, and we found 
no relationship between the frequency of seizure 
(p=0.36) and the patients’ gender (p = 0.874), 
age (p=0.814), type of seizure (p = 0.396), body 
temperature (p = 0.643), cause of febrile seizure 
(p = 0.051), family history of febrile seizure (p = 
0.729), family history of seizure (p = 0.355),  and 
time between fever and seizure (p = 0.211). 
Tablel 1. Recurrence frequency of febrile seizure in four groups.
Recurrence frequency total
No Yes
Type of drug No drug 59 9 68
86/8% 13/2% 100%
Tab diazepam 61 2 63
83/96% 17/3% 100%
Phenobarbital (single dose) 57 1 58
98/3% 1/7% 100%
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Discussion
This study was conducted at the Department of 
Pediatrics during September 2015 and September 
2016. The purpose of this study was to evaluated 
the effect of prophylaxis treatment in the acute 
febrile stage after the FC in children. The use of 
diazepam and phenobarbital (either as a single 
dose or as continuous) were effective in preventing 
the recurrence of FC in the acute stage. Diazepam 
and a single dose of phenobarbital were 4.5 and 
8.7 times more effective than non-drug use in 
preventing the recurrence of FC in the acute stage.
It  was also found that FC recurrence was not 
significantly associated with age, sex, recurrence, 
rate, duration of fever to seizure, type of FC, cause 
of fever, family history of FC, family history 
of epilepsy, hyponatremia, and preservation in 
kindergarten. 
In the present, the recurrence rate  of  FC in the 
acute stage  was 4.84%. Barzegar et al. (16) in 
2009 reported that recurrence rate in the acute stage 
was 18.6% in a no  drug  group and 2.8% in oral 
and intravenous phenobarbital  groups. In 2006, 
Barzegar et al. (17)  concluded that recurrence rate 
in the acute phase was 15% in a no  drug group 
and 1% in a phenobarbital group. In the study of 
Hirabayashi et al. (18), 203 children with FC were 
included. They were given diazepam suppository 
in the acute phase of illness, while the control 
group did not receive any drugs. It was reported 
that the recurrence rate was 2.1% in the diazepam 
group, and 14.8% in the no-drug group. It can be 
stated that the only predictor of the recurrence of 
FC in the acute stage in our study was the type 
of treatment protocol. Although   FC is a benign 
phenomenon, since most studies report the highest 
rate of recurrence in the first year and in the first 
24 hours, administering drugs to the child in the 
acute stage of  FC has more advantages than 
disadvantages.
In the present study, the mean age of the patients was 
22 months, which was comparable to participants 
enrolled by Nelson et al. study (1), where the mean 
age was 23.3 months, and Manish et al. (19) and 
Fallah et al. studies (20), where the mean age was 
26.72 and 24.3 months, respectively. All of these 
studies showed a significant relationship between 
age at FC and recurrence.  Similar  to our study, 
Ojha et al. (21) did not prove such a relationship.
In the present study, the mean interval between 
fever onset and seizure occurrence was 19.35 
hours. Hence, there was no significant association 
between the recurrence of FC and  duration of 
fever. Similarly, the studies conducted by Chan 
et al. (22) and Manish et al.  also did not show a 
significant relationship between recurrent FC  and 
shorter duration of fever before onset of seizure. 
Studies by Ojha et al., Talebian et al. (23), and 
Fallah et al. showed a significant link between 
recurrent FC and shorter duration of fever before 
onset of seizure.
In our study, the prevalence of FC was higher in 
boys, but there was no significant relationship 
between gender and recurrence. This result was 
consistent with the results of Fallah et al. and Chan 
et al., but it was not compatible with the findings of 
Bessisso et al. (24) and Agrawal et al. (25).
In the present study, the family history of FC and 
epilepsy was present in one-third  and  one-seventh 
of the subjects. The association between the family 
history of FC or epilepsy and the recurrence was not 
found to be statistically significant, which is similar 
to the results of Talebian et al., Manish et al., and 
Ojha et al. However, Nelson et al. and Berg et al. 
(26) showed a strong association between family 
history and recurrence. The genetic contribution to 
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the incidence of FC was manifested by a positive 
family  history of FC in several patients. In some 
families, the disorder was inherited as an autosomal 
dominant trait, and the multiple and single genes 
causing  the disorder  appear to be polygenic, but 
the predisposing genes remain to be identified.
The type of seizure of the patients was simple, 
which is consistent the studies of Imani et al. (26), 
and Salehi (27), but in the study by Agrawal (24) 
most patients had complex FC; this discrepancy 
could be due to geographical and race differences.
In the present study, the highest rate of recurrence 
was in recurrent FC, followed by simple and 
complex FC. Therefore, there was no  significant 
association between recurrence and type of 
seizure, which is consistent with the findings of 
Manish et al., Chan et al., Fallah et al., and Berg et 
al. However, Ojha et al. and Leung et al. (28) found 
a significant  association between the complex 
type of seizure and FC recurrence. Considering 
that complex FC is a minor risk factor for the 
recurrence of seizure, it seems that the reason 
for the low recurrence rate in our study is a short 
follow-up period (in the acute stage). Race  and 
geographical differences can also account for the 
low prevalence of complex FC in our study. A 
similar study with a larger sample size is suggested 
to corroborate our findings. In the present study, 
the most important causes of fever included upper 
respiratory infection, gastroenteritis, UTI, and 
other infectious causes, respectively.
In Conclusion
Controlling seizures without prescribing 
anti-seizure drugs increases the risk for the 
recurrence of febrile seizure in the acute stage. 
Different drug regimens for controlling seizure, 
including diazepam and phenobarbital (as stat or 
maintenance), may play a similar role in preventing 
the occurrence of febrile seizure.  
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